Literature DB >> 16211090

The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Sarah E Allan1, Laura Passerini, Rosa Bacchetta, Natasha Crellin, Minyue Dai, Paul C Orban, Steven F Ziegler, Maria Grazia Roncarolo, Megan K Levings.   

Abstract

Little is known about the molecules that control the development and function of CD4+ CD25+ Tregs. Recently, it was shown that the transcription factor FOXP3 is necessary and sufficient for the generation of CD4+ CD25+ Tregs in mice. We investigated the capacity of FOXP3 to drive the generation of suppressive CD4+ CD25+ Tregs in humans. Surprisingly, although ectopic expression of FOXP3 in human CD4+ T cells resulted in induction of hyporesponsiveness and suppression of IL-2 production, it did not lead to acquisition of significant suppressor activity in vitro. Similarly, ectopic expression of FOXP3delta2, an isoform found in human CD4+ CD25+ Tregs that lacks exon 2, also failed to induce the development of suppressor T cells. Moreover, when FOXP3 and FOXP3delta2 were simultaneously overexpressed, although the expression of several Treg-associated cell surface markers was significantly increased, only a modest suppressive activity was induced. These data indicate that in humans, overexpression of FOXP3 alone or together with FOXP3delta2 is not an effective method to generate potent suppressor T cells in vitro and suggest that factors in addition to FOXP3 are required during the process of activation and/or differentiation for the development of bona fide Tregs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16211090      PMCID: PMC1242190          DOI: 10.1172/JCI24685

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

Review 1.  Control of T-cell activation by CD4+ CD25+ suppressor T cells.

Authors:  E M Shevach; R S McHugh; C A Piccirillo; A M Thornton
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

2.  Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.

Authors:  L S Taams; J Smith; M H Rustin; M Salmon; L W Poulter; A N Akbar
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

3.  Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation.

Authors:  L A Schubert; E Jeffery; Y Zhang; F Ramsdell; S F Ziegler
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

4.  Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

Authors:  W F Ng; P J Duggan; F Ponchel; G Matarese; G Lombardi; A D Edwards; J D Isaacs; R I Lechler
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

Review 5.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

6.  Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.

Authors:  Giovanna Roncador; Philip J Brown; Lorena Maestre; Sophie Hue; Jorge L Martínez-Torrecuadrada; Khoon-Lin Ling; Sarah Pratap; Christy Toms; Bridget C Fox; Vincenzo Cerundolo; Fiona Powrie; Alison H Banham
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

7.  Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.

Authors:  D Dieckmann; H Plottner; S Berchtold; T Berger; G Schuler
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

8.  Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

Authors:  M K Levings; R Sangregorio; M G Roncarolo
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

9.  Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.

Authors:  Megan K Levings; Romina Sangregorio; Claudia Sartirana; Anna Lisa Moschin; Manuela Battaglia; Paul C Orban; Maria-Grazia Roncarolo
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

10.  Identification of regulatory T cells in tolerated allografts.

Authors:  Luis Graca; Stephen P Cobbold; Herman Waldmann
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more
  163 in total

1.  Paradoxically increased FOXP3+ T cells in IBD do not preferentially express the isoform of FOXP3 lacking exon 2.

Authors:  James D Lord; Karine Valliant-Saunders; Hejin Hahn; Richard C Thirlby; Steven F Ziegler
Journal:  Dig Dis Sci       Date:  2012-06-27       Impact factor: 3.199

Review 2.  An update on regulatory T cells in transplant tolerance and rejection.

Authors:  Xian Chang Li; Laurence A Turka
Journal:  Nat Rev Nephrol       Date:  2010-08-03       Impact factor: 28.314

Review 3.  Induced regulatory T cells: mechanisms of conversion and suppressive potential.

Authors:  Eefje M Dons; Giorgio Raimondi; David K C Cooper; Angus W Thomson
Journal:  Hum Immunol       Date:  2012-01-14       Impact factor: 2.850

4.  Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3.

Authors:  Angelika Schmidt; Francesco Marabita; Narsis A Kiani; Catharina C Gross; Henrik J Johansson; Szabolcs Éliás; Sini Rautio; Matilda Eriksson; Sunjay Jude Fernandes; Gilad Silberberg; Ubaid Ullah; Urvashi Bhatia; Harri Lähdesmäki; Janne Lehtiö; David Gomez-Cabrero; Heinz Wiendl; Riitta Lahesmaa; Jesper Tegnér
Journal:  BMC Biol       Date:  2018-05-07       Impact factor: 7.431

Review 5.  Immunopathogenesis of IBD: insufficient suppressor function in the gut?

Authors:  I L Huibregtse; A U van Lent; S J H van Deventer
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

Review 6.  Epithelia: lymphocyte interactions in the gut.

Authors:  Stephanie Dahan; Franziska Roth-Walter; Paul Arnaboldi; Shradha Agarwal; Lloyd Mayer
Journal:  Immunol Rev       Date:  2007-02       Impact factor: 12.988

7.  The role of the CD58 locus in multiple sclerosis.

Authors:  Philip L De Jager; Clare Baecher-Allan; Lisa M Maier; Ariel T Arthur; Linda Ottoboni; Lisa Barcellos; Jacob L McCauley; Stephen Sawcer; An Goris; Janna Saarela; Roman Yelensky; Alkes Price; Virpi Leppa; Nick Patterson; Paul I W de Bakker; Dong Tran; Cristin Aubin; Susan Pobywajlo; Elizabeth Rossin; Xinli Hu; Charles W Ashley; Edwin Choy; John D Rioux; Margaret A Pericak-Vance; Adrian Ivinson; David R Booth; Graeme J Stewart; Aarno Palotie; Leena Peltonen; Bénédicte Dubois; Jonathan L Haines; Howard L Weiner; Alastair Compston; Stephen L Hauser; Mark J Daly; David Reich; Jorge R Oksenberg; David A Hafler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 8.  Histone deacetylase inhibitors and transplantation.

Authors:  Ran Tao; Edwin F de Zoeten; Engin Ozkaynak; Liqing Wang; Bin Li; Mark I Greene; Andrew D Wells; Wayne W Hancock
Journal:  Curr Opin Immunol       Date:  2007-08-24       Impact factor: 7.486

9.  Dissecting the role of the FOXP3 gene in the joint genetic susceptibility to autoimmune thyroiditis and diabetes: a genetic and functional analysis.

Authors:  Cheuk Wun Li; Erlinda Concepcion; Yaron Tomer
Journal:  Gene       Date:  2014-12-03       Impact factor: 3.688

Review 10.  Regulatory T Cells: Central Concepts from Ontogeny to Therapy.

Authors:  Bernard Khor
Journal:  Transfus Med Rev       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.